share_log

Eiger BioPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Propel Bio Management LLC(10.9%),Leen Kawas(10.9%), etc.

Eiger BioPharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Propel Bio Management LLC(10.9%),Leen Kawas(10.9%)等

美股sec公告 ·  2023/09/28 16:54
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息